Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Vox Sanguinis|November 5, 1999
Use of recombinant, activated factor VII in the treatment of congenital factor VII deficienciesG Mariani, M G Testa, T Di Paolantonio, et al.
Diabetes, Nutrition & Metabolism|May 29, 2000
Personality variables and compliance with insulin therapy in Type 2 diabetic subjectsP Gentili, A Maldonato, D Bloise, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|February 1, 2019
Impact of vulvovaginal atrophy of menopause: prevalence and symptoms in Italian women according to the EVES studyR E Nappi, R Seracchioli, S Salvatore, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1987
Inhibitor to factor VIII in a non-haemophilic patient: evaluation of the response to DDAVP and the in vitro kinetics of factor VIII. A case reportA Chistolini, A Ghirardini, M C Tirindelli, et al.
American Journal of Hematology|January 1, 1990
Carrier detection for hemophilia B: evaluation of multiple polymorphic sitesG Mariani, A Chistolini, H J Hassan, et al.
Thrombosis Research|February 1, 1988
Clinical evaluation of subcutaneously administered DDAVPA Ghirardini, A Chistolini, M C Tirindelli, et al.
Journal of Medical Virology|February 1, 1992
Low risk of transmission of the human immunodeficiency virus by a solvent-detergent-treated commercial factor VIII concentrateT Di Paolantonio, G Mariani, A Ghirardini, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 17, 2005
Prolonged prothrombin time, Factor VII and activated FVII levels in chronic liver disease are partly dependent on Factor VII gene polymorphismsS Grimaudo, A Craxi, S Gentile, et al.
Pageof 2